Operating as a global central clinical laboratory for pharmaceutical companies and performing sample analyses in the framework of clinical trials (phases I to IV), BARC is committed to adhere to strict quality assurance guidelines in order to fulfill the requirements of the client who needs to work under Good Clinical Practices (GCP/GCLP).
A broad range of accreditations and certifications ensure stringent quality management in all aspects of our organization.
Consistency and quality is the key to BARC’s success. As such, processes have been put in place to ensure laboratory results are meticulously monitored with daily instrument calibrations and an extensive internal quality control program.
In addition, all laboratories participate in a large range of external proficiency testing schemes such as CAP, NEQAS, CDC, NGSP and various national and commercial programs.
BARC’s Global Quality Assurance department, which is fully independent from its operations, is responsible for issuing and reviewing standard operating procedures (SOP’s) and working instructions, performing internal and hosting sponsor audits.
Client feedback, originating from surveys, audits or complaints, are centralised through our QA department and are used for continuous process improvement. Each finding or complaint is submitted to an in depth root cause investigation in order to define appropriate corrective and/or preventive actions (CAPA’s).